Technology News and Research

RSS

Virginia Mason first to use non-invasive FibroScan technology to evaluate liver diseases

Virginia Mason today becomes the first in the Pacific Northwest to use non-invasive FibroScan technology to evaluate disease stage in patients diagnosed with liver ailments.

3 Dec 2013

Investigators use new technique to identify pathogens faster, directly from clinical samples

A team of Danish investigators has shown how to identify pathogens faster, directly from clinical samples. The research, published online ahead of print in the Journal of Clinical Microbiology appears in the journal's January 2014 issue.

2 Dec 2013

Xagenic announces closing of $20 million Series B financing

Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, today announced the close of a Series B financing totaling $20 million. The round was led by new investor Domain Associates, LLC, which was joined by existing investors including CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.

2 Dec 2013

First Edition: December 2, 2013

Today's early morning highlights from the major news organizations, including reports about healthcare.gov's status, the challenges that lie ahead and the concerns being expressed by consumers and insurers.

2 Dec 2013

Toshiba's M-Power interface simplifies MR scans and helps improve patient care

Healthcare providers are able to do more with less and improve patient care thanks to Toshiba America Medical Systems, Inc.'s enhanced M-Power user interface. Toshiba's M-Power interface simplifies MR scans by automatically guiding clinicians to complete exams accurately and efficiently. Combined with the large bore, quiet MR technology and advanced non-contrast techniques of Toshiba's MR systems, clinicians can offer an overall more comfortable and safer exam.

2 Dec 2013

JHL Biotech installs GE Healthcare's FlexFactory biomanufacturing platform at Hsinchu plant in Taiwan

GE Healthcare Life Sciences and JHL Biotech today announced that GE Healthcare has completed installation of its FlexFactory biomanufacturing platform at JHL Biotech's Research Center and manufacturing plant in Hsinchu, Taiwan.

2 Dec 2013

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.

2 Dec 2013

New biomarkers to improve diagnostics of prostate cancer

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.

2 Dec 2013

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.

2 Dec 2013

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing, today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

2 Dec 2013

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

To be published online Monday, Dec. 2, a special issue of the Journal of the American College of Radiology addresses imaging-based screening and radiology's increasing role in preventive medicine. Topics covered include breast density legislation, digital breast tomosynthesis (or 3-D mammography), lung cancer screening and computed tomography colonography reimbursement.

2 Dec 2013

World-class Krembil Discovery Tower now opens in Canada

The Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women congratulated Toronto Western Hospital today on the opening of the Krembil Discovery Tower, a facility dedicated to research excellence, training the next generation of medical professionals and improving health care for patients across Canada.

2 Dec 2013

Scientists transform human stem cells into functional lung and airway cells

For the first time, scientists have succeeded in transforming human stem cells into functional lung and airway cells. The advance, reported by Columbia University Medical Center researchers, has significant potential for modeling lung disease, screening drugs, studying human lung development, and, ultimately, generating lung tissue for transplantation.

2 Dec 2013

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.

2 Dec 2013

GE Healthcare introduces new Invenia Automated Breast Ultrasound System at RSNA 2013

GE Healthcare, a unit of General Electric Company, introduced today the new Invenia Automated Breast Ultrasound System at the 2013 Radiological Society of North America annual meeting.

2 Dec 2013

Toshiba's Dose Tracking System optimizes dose management to improve patient safety

For the first time ever, clinicians have the flexibility to track X-ray skin dose exposure in real time during interventional procedures with Toshiba America Medical Systems, Inc.'s Dose Tracking System. FDA cleared on Toshiba's InfinixTM-i cardiovascular X-ray systems for use in pediatric and adult cardiac and abdominal procedures, the new technology is Toshiba's latest advancement in optimizing dose management to improve patient safety.

2 Dec 2013

Administration gives positive progress report on health care website fixes

Obama administration officials announced Sunday morning that they had met their deadline in terms of making improvements to healthcare.gov.

1 Dec 2013

NDSC offers free trial access to ACR Select portal

National Decision Support Company, the American College of Radiology's partner for the distribution of the ACR Appropriateness Criteria is offering free trial access to its ACR Select portal.

1 Dec 2013

Royal Philips showcases EPIQ and AlluraClarity systems at RSNA 2013

Today, at the 99th Annual Meeting of the Radiological Society of North America in Chicago, Royal Philips showcases its EPIQ premium ultrasound system that combines an exceptional level of clinical performance, advanced system intelligence and intuitive design, and its AlluraClarity interventional X-ray system that provides high quality imaging for a comprehensive range of clinical procedures, achieving excellent visibility at low X-ray dose levels for patients of all sizes.

From Philips Healthcare 1 Dec 2013

People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

People living with chronic fatigue are set to benefit with the opening next week (Dec 2), of the National Centre for Neuroimmunology and Emerging Diseases at Griffith University.

30 Nov 2013

Technology News and Research

Virginia Mason first to use non-invasive FibroScan technology to evaluate liver diseases

Investigators use new technique to identify pathogens faster, directly from clinical samples

Xagenic announces closing of $20 million Series B financing

First Edition: December 2, 2013

Toshiba's M-Power interface simplifies MR scans and helps improve patient care

JHL Biotech installs GE Healthcare's FlexFactory biomanufacturing platform at Hsinchu plant in Taiwan

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

New biomarkers to improve diagnostics of prostate cancer

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

World-class Krembil Discovery Tower now opens in Canada

Scientists transform human stem cells into functional lung and airway cells

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

GE Healthcare introduces new Invenia Automated Breast Ultrasound System at RSNA 2013

Toshiba's Dose Tracking System optimizes dose management to improve patient safety

Administration gives positive progress report on health care website fixes

NDSC offers free trial access to ACR Select portal

Royal Philips showcases EPIQ and AlluraClarity systems at RSNA 2013

People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News